home / stock / goss / goss short
Short Information | Gossamer Bio Inc. (NYSE:GOSS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 240,539 |
Total Actual Volume | 8,145,536 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 12,027 |
Average Short Percentage | 2.86% |
Is there a GOSS Short Squeeze or Breakout about to happen?
See the GOSS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $15.02 | $15.21 | $15.22 | $14.79 | 313,154 | 4,122 | 1.32% |
02-11-2020 | $15.16 | $15.03 | $15.29 | $14.8401 | 393,304 | 7,213 | 1.83% |
02-10-2020 | $14.91 | $15.14 | $15.29 | $14.70 | 329,741 | 15,828 | 4.8% |
02-07-2020 | $14.62 | $14.80 | $14.83 | $14.25 | 288,892 | 6,061 | 2.1% |
02-06-2020 | $14.84 | $14.62 | $14.894 | $14.43 | 288,729 | 5,336 | 1.85% |
02-05-2020 | $13.89 | $14.67 | $14.93 | $13.78 | 399,976 | 10,625 | 2.66% |
02-04-2020 | $13.66 | $13.84 | $14.05 | $13.51 | 243,088 | 7,280 | 2.99% |
02-03-2020 | $13.39 | $13.64 | $13.97 | $13.34 | 378,330 | 4,075 | 1.08% |
01-31-2020 | $13.50 | $13.28 | $13.56 | $13.15 | 333,384 | 4,305 | 1.29% |
01-30-2020 | $13.58 | $13.53 | $13.90 | $13.30 | 315,292 | 10,654 | 3.38% |
01-29-2020 | $13.95 | $13.68 | $14.07 | $13.435 | 383,163 | 23,499 | 6.13% |
01-28-2020 | $14.02 | $13.93 | $14.12 | $13.53 | 359,105 | 10,328 | 2.88% |
01-27-2020 | $13.45 | $13.89 | $14.09 | $13.13 | 512,646 | 22,817 | 4.45% |
01-24-2020 | $13.42 | $13.33 | $13.855 | $13.15 | 630,975 | 29,313 | 4.65% |
01-23-2020 | $13.99 | $13.37 | $14.00 | $13.17 | 910,401 | 34,563 | 3.8% |
01-22-2020 | $14.06 | $13.46 | $14.18 | $13.31 | 366,518 | 9,640 | 2.63% |
01-21-2020 | $14.22 | $13.97 | $14.5565 | $13.88 | 475,788 | 15,719 | 3.3% |
01-17-2020 | $15.15 | $14.34 | $15.26 | $14.34 | 238,879 | 9,877 | 4.13% |
01-16-2020 | $15.16 | $15.00 | $15.47 | $14.7908 | 557,212 | 4,960 | 0.89% |
01-15-2020 | $14.60 | $15.04 | $15.15 | $14.60 | 426,959 | 4,324 | 1.01% |
News, Short Squeeze, Breakout and More Instantly...
2024-03-20 10:20:00 ET March 20, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies are involved in immuno-oncology, ...
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced...
- First PAH Patient Dosed in Ongoing Registrational Phase 3 PROSERA Study - - Inclusion of Japan in Phase 3 PROSERA Study Following CTN Acceptance by PMDA - - Cash, cash equivalents and marketable securities totaled $296 million at year-end 2023 - Gossamer Bio, Inc. (Nas...